| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.099 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |